How the Middle East Is Exposing Defence Production Limits
6 March 2026.
Middle East missile campaigns expose interceptor shortages and accelerate missile defence production investment.
Newsletter
Precision Payloads: The Rise of Antibody Drug Conjugates in Modern Oncology
4 March 2026.
Antibody drug conjugates are reshaping oncology through precision targeting, expanding pipelines and industry partnerships
Procurement: Sovereignty Is Rewriting the Rules
27 February 2026.
Defence spending rises, but industrial alignment now decides contract winners.
Durability and Delivery: How Biologics Are Redefining Ophthalmology
25 February 2026.
Ophthalmology shifts to durable growth through biologics, delivery innovation and consolidation.
Defence’s New Battleground: Manufacturing Power
20 February 2026.
Manufacturing power now shapes defence procurement, sovereignty and global partnerships.
Transatlantic Defence Trade Realignment
13 February 2026.
US export strategy and UK procurement delays reshape defence competition dynamics
Fill-Finish Manufacturing Is Now a Strategic Constraint
11 February 2026.
Fill-finish capacity now defines biologics launches, valuation strength, and competitive leverage
Why Speed Is Now Deciding Defence Contracts
6 February 2026.
Defence procurement balances rapid modernisation with sustained readiness and industrial resilience
Drug Discovery Outsourcing as Strategy: ROI, Agility, and Advantage
4 February 2026.
Drug discovery outsourcing reshapes pipeline speed, capital efficiency, and competitive advantage
Spending Evolves as Governments Intervene
16 January 2026.
Defence investment shifts toward direct intervention, scalable production and supply-chain resilience
Beyond AMD: Breakthroughs in Geographic Atrophy
3 December 2025.
Geographic atrophy market accelerates as therapies, diagnostics and investment expand
Hybrid Generics & VAMs Accelerate the Innovation Curve
19 November 2025.
Differentiated hybrids and VAMs strengthen competitiveness, extend lifecycles and unlock sustainable growth beyond price competition.
Pharma’s Next Horizon: AI, Sustainability & Human Insight Meet at CPHI Europe 2025
30 October 2025.
CPHI Europe highlights AI, regional manufacturing, sustainability and biopharma collaboration
CPHI Europe 2025 Day 2: AI, Agility and Collaboration Drive the Next Chapter
29 October 2025.
Pharma leaders embrace partnerships, agility and next-generation manufacturing at CPHI
European Defence Resilience and Market Realignment
23 October 2025.
Europe shifts toward defence sovereignty amid realignment and investment growth
Breakthroughs in Advanced Therapies
1 August 2025.
From gene therapy to regenerative medicine—discover the breakthroughs reshaping the future of healthcare
Precision Medicine Transforming Patient Care
30 July 2025.
Discover how precision medicine is reshaping healthcare with tailored treatments, breakthrough therapies, and innovation
The UK’s Declining Access to Rare Disease Medicines: An Urgent Challenge
13 March 2025.
The UK’s leadership in rare disease medicine is at risk—will patients lose access to innovation?
